News
The goal is to reuse key parts of the treatment and simply swap in a custom set of instructions for each patient's specific ...
The Crispr therapy was tailored to the baby’s specific condition and could provide a template for others.
Nine-year-old Addy Clarke, from Swindon, has Batten Disease - a rare degenerative disease that has no cure. An agreement has ...
Most of the 15 million children with a rare disease have no FDA-approved treatments available to them. And when it comes to ...
Telomir Pharma (NASDAQ: TELO) secured $3M in equity financing from Bayshore Trust, its largest shareholder, at $3 per share ...
Investment from largest shareholder strengthens balance sheet, signals insider conviction, and funds Telomir-1’s upcoming IND submission for a rare disease indication ...
While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...
1d
Smithsonian Magazine on MSNIn a Remarkable First, a Baby With a Rare Disease Receives Personalized Gene TherapyResearchers say the CRISPR-based technique used could eventually be employed to treat more people with rare genetic diseases ...
Applied Therapeutics’ rare disease drug has failed another late-stage clinical trial, adding to the woes of a candidate that ...
When an Omaha woman was diagnosed with a rare illness as a teenager, it affected not only her health but also her high school ...
A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...
An infant with a rare urea cycle disorder became the first patient to receive a personalized gene-editing therapy. His care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results